Adastra's license also allows it to produce and market psilocybin and psilocin -- hallucinogens much more frequently generally known as magic mushrooms that generate outcomes much like LSD. The licensing offer comes following a radical policy change to deal with an opioid overdose crisis that has killed 1000's, by decriminalizing modest quantiti